CSPC Pharmaceutical Group Ltd (NASDAQ:CHPTY) Upgraded to Hold by Zacks Investment Research

CSPC Pharmaceutical Group Ltd (NASDAQ:CHPTY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday, September 13th.

According to Zacks, “CSPC Pharmaceutical Group Limited operates as a pharmaceutical group in China. Its bulk drug products include vitamin C, penicillin G and 7-ACA. The Company is also a major manufacturer of antibiotic finished drugs such as penicillin and cephalosporin products. CSPC Pharmaceutical Group Limited, formerly known as China Pharmaceutical Group Limited, is based in Wan Chai, Hong Kong. “

CSPC Pharmaceutical Group (CHPTY) remained flat at $80.04 during midday trading on Wednesday. CSPC Pharmaceutical Group has a 12 month low of $48.25 and a 12 month high of $80.04. The firm has a 50 day moving average price of $74.62 and a 200 day moving average price of $69.72. The firm has a market cap of $9.69 billion and a PE ratio of 32.02.

WARNING: This piece of content was originally published by BBNS and is the property of of BBNS. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://baseballnewssource.com/markets/cspc-pharmaceutical-group-ltd-chpty-upgraded-at-zacks-investment-research/1643753.html.

CSPC Pharmaceutical Group Company Profile

CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs).

Get a free copy of the Zacks research report on CSPC Pharmaceutical Group (CHPTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CSPC Pharmaceutical Group Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group Ltd and related companies with our FREE daily email newsletter.

 


Latest News

Bryce Harper Hoping to Return Monday from Knee Injury
Bryce Harper Hoping to Return Monday from Knee Injury
American League Once Again Dominates National League
American League Once Again Dominates National League
Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?


Leave a Reply

 
© 2006-2017 BBNS.